Scroll Top
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Related Posts
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Related Posts
STAR Compounds Show Potential to Treat GBA1-linked Parkinson’s
Parkinsons News Today
Related Posts
Post navigation
Previous Post
The Society Of Neuroscience Annual Meeting
Next Post
Gain Therapeutics, Inc. Reports Third Quarter 2021 Financial Results and Business Update
Latest Articles
Clear Filters
March 24, 2022
Gain Therapeutics, Inc. Reports Full Year 2021 Financial Results and Business Update
Read More
February 14, 2024
Data shows restored motor function in mouse models of Parkinson’s disease
Read More
December 15, 2020
GT Gain Therapeutics SA Announces Funding from the Swiss Innovation Agency Supporting a 3-year Research Collaboration Project with the Institute for Research in Biomedicine and Neurocentro
Read More
Close